Delivery Order SPE2DB24D2013-SPE2DB26FCGRD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This contract represents a firm fixed-price delivery order with a ceiling value of $3,057.33 and an ultimate completion date of August 15, 2025. The award was made through open competition with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,249.56. This firm fixed-price delivery order, which was not set-aside and competitively awarded, was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epinephrine 0.3 MG auto-injector, 2-pack units, with a ceiling value of $5,500.94 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,732.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,954.60 with a firm fixed price structure. The order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside award issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $14,125.92 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply chain requirements. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $23,293.20 delivery order on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs on September 3, 2025, with a ceiling value of $11,698.06. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with a completion date of September 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,237.60. This competitively awarded, non-set-aside contract was executed on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed-price delivery order represents a component of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $2,704.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB26FCGRDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units per pack). This firm fixed price delivery order, valued at $4,035.65, represents a non-set-aside competitive award with an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies critical medications, medical devices, and healthcare commodities to support military and veteran healthcare systems worldwide. The parent IDC enables flexible procurement of pharmaceutical products across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/27/25 |